COVID-19 Statement

In light of the global spread of COVID-19, which has affected us all, FIDE is refocusing its priorities and will join the efforts of other organizations to do everything possible to prevent the spread of this disease, and ensure the health and wellbeing of its team members, colleagues, and the general population. In the short term, all our team are working remotely and will be unable to provide you with the usual face-to-face opportunities. However, we remain committed to doing everything we can to support our clients and ensure improved outcomes for patients. To this end, we are offering virtual training and consulting solutions that can help you adapt to evolving market scenarios.

Meet the Experts

Icon_Border Bruce-E-Strober

Bruce E Strober, MD, PhD

Senior Partner

Department of Dermatology, Yale University, New Haven, CT, USA
Central Connecticut Dermatology Research, Cromwell, CT, USA

Dr Strober is Clinical Professor of Dermatology at Yale University School of Medicine, and practices at Central Connecticut Dermatology. He is also co-Scientific Director of the CorEvitas psoriasis registry, Secretary/Treasurer of the International Psoriasis Council, and Editor in chief of the Journal of Psoriasis and Psoriatic Arthritis.

Dr Strober earned both his medical degree and his doctorate from Columbia University College of Physicians and Surgeons in New York. He completed his residency in dermatology at the Department of Dermatology, New York University School of Medicine. He is certified by the American Board of Dermatology and is a Fellow of the American Academy of Dermatology.

Dr Strober's research interests include the study of therapeutics, both old and new, for inflammatory skin disease, specifically interventions that help patients with difficult-to-treat psoriasis, alopecia areata, atopic dermatitis, and hidradenitis suppurativa. He has served as principal investigator or sub-investigator for numerous multicenter clinical studies. His primary clinical focus is the treatment of moderate to severe plaque psoriasis and atopic dermatitis.

Dr Strober was Chair of the University of Connecticut Department of Dermatology from 2015–18. He has served as a Section Editor for the British Journal of Dermatology, and is an ad hoc reviewer for the Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, and Inflammation. He has published more than 160 book chapters and articles in peer-reviewed journals such as the New England Journal of Medicine, JAMA Dermatology, Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, and the Journal of the American Medical Association, among others. Dr Strober also has presented data to the FDA on behalf of multiple pharmaceutical companies, including at the advisory committee for secukinumab.

Icon_Border Kenneth-B-Gordon

Kenneth B Gordon, MD

Partner

Partner Department of Dermatology, Medical College of Wisconsin,
Milwaukee, WI, USA

Dr Gordon is Thomas J Russell Family/Milwaukee Community Dermatologists Professor and Chair of Dermatology at the Medical College of Wisconsin.

Previously, Dr Gordon served as Professor of Dermatology at Northwestern University, Feinberg School of Medicine, Chicago, and Associate Director at the Center for Clinical Research, Northwestern University Center for Clinical and Translational Science.

Dr Gordon received his medical degree from Columbia University, New York. In his position as a member of the American Academy of Dermatology, Dr Gordon has chaired several sessions at the annual meeting, and is on the Working Group on Psoriasis and Psoriatic Arthritis.

Dr Gordon has published widely in several journals including the Journal of the American Academy of Dermatology and the Lancet, and he is a reviewer for others, such as the British Journal of Dermatology and the New England Journal of Medicine. His main research interests are therapies for psoriasis and psoriatic arthritis, and he has contributed to the development of the AAD treatment guidelines for these diseases.

Icon_Border Kristian-Reich

Kristian Reich, MD, PhD

Partner

Translational Research in Inflammatory Skin Diseases,
Institute for Health Services Research in Dermatology and Nursing,
University Medical Center, Hamburg-Eppendorf, Hamburg, Germany

Dr Reich is Professor for Translational Research in Inflammatory Skin Diseases at the Institute for Health Services Research in Dermatology and Nursing at the University Medical Center.

Professor Reich's main research interests include genetic and immunologic mechanisms of cutaneous inflammation and cancer, translational health care research in psoriasis and atopic dermatitis, and the development of new therapies for skin diseases. He has published more than 300 articles in international peer-reviewed journals, including the Lancet, New England Journal of Medicine, Journal of Immunology, and the Journal of Allergy and Clinical Immunology. Professor Reich chairs the scientific committee of the German Psoriasis Registry PsoBest, is a member of the board of PsoNet and the ProDerma foundation in Hamburg, and is a member of the board of trustees of the Alfred-Marchionini foundation. He is also a counselor for the International Psoriasis Council and the International Eczema Council.

Professor Reich has received numerous prizes and awards, including the Herbert-Herxheimer Research Prize of the German Society for Immunology and Allergology (2003), the RK Schachter Lectureship (2012), and the Stars of the Academy Award of the American Academy of Dermatology (2016).

Icon_Border Richard-GB-Langley

Richard GB Langley, MD

Partner

Department of Medicine, Dalhousie University, Halifax, NS, Canada

Dr Langley is Professor and Director of Research in the Division of Dermatology, Department of Medicine at Dalhousie University in Canada, and was President of the Canadian Dermatology Association in 2014.

Dr Langley received his undergraduate degree at Dalhousie University, his internship in internal medicine and fellowship in dermatologic surgery at the University of Toronto, Canada, and completed his fellowship training at Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Following his training, Dr Langley joined the Faculty of Medicine at Harvard Medical School, and was Director of Clinical Investigations Unit at Massachusetts General Hospital until June 2000.

Dr Langley has authored over 300 articles, book chapters, and other publications and he is a regular reviewer for several medical and dermatology journals. He is a principal investigator and has conducted over 250 Phase 1–3 studies involving most of the biologic agents in psoriasis and new immunotherapies in atopic dermatitis. He also has an imaging laboratory that has helped pioneer the application of diagnostic in vivo confocal microscopy in benign and malignant melanocytic lesions.

Our partners are supported by an extensive network of global experts working in academia and community-based practices, providing both evidence-based and pragmatic perspectives.

Meet the team

Icon_Border Oliver Dennis

Oliver Dennis

Partner

Icon_Border Steve Annels

Steve Annels

Consultant

Icon_Border Tom Middlebrook

Tom Middlebrook

Senior Manager

Icon_Border Steve Dobson

Steve Dobson

Scientific Solutions Consultant

Icon_Border Scott Chambers

Scott Chambers

Scientific Solutions Consultant

Icon_Border Devon Allen

Devon Allen

Associate Scientific Solutions Consultant

Icon_Border Asa Hartfil

Asa Hartfil

Senior Manager, Core Services

Icon_Border Laura Lewis

Laura Lewis

Manager, Core Services

Icon_Border Tom Stubbs

Tom Stubbs

Manager